Retractable Technologies (RVP) Net Income towards Common Stockholders (2010 - 2026)
Retractable Technologies' (RVP) quarterly Net Income towards Common Stockholders came in at -$4.3 million in Q1 2026, up 59.44% YoY from -$2.7 million in Q1 2025, and down 78.03% on a QoQ basis from -$2.4 million in Q4 2025.
Retractable Technologies (RVP) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Retractable Technologies (RVP) has 17 years of Net Income towards Common Stockholders data on file, last reported at -$4.3 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 59.44% year-over-year to -$4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.5 million (up 71.71% YoY) and the FY2025 annual result came in at -$12.8 million, down 5.6% from the prior year.
- Net Income towards Common Stockholders declined to -$4.3 million in Q1 2026, from -$2.4 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $7.6 million in Q1 2022 to a low of -$14.2 million in Q2 2024.
- A 5-year average of -$1.9 million and a median of -$2.0 million in 2024 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders jumped 2944.05% — and 2025, when it sank 2939.99%.
- Tracing RVP's Net Income towards Common Stockholders over 5 years: stood at -$4.3 million in 2022, then jumped by 96.99% to -$130557.0 in 2023, then jumped by 2944.05% to $3.7 million in 2024, then slumped by 164.79% to -$2.4 million in 2025, then plunged by 78.03% to -$4.3 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$4.3 million (Q1 2026), -$2.4 million (Q4 2025), and $313436.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 378.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 126.00 Mn |
| 10 | Retractable Technologies | 21.84 Mn | -18.03 Mn | 190,852.00 | 2.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.28 Mn |
| Dec 31, 2025 | -2.41 Mn |
| Sep 30, 2025 | 313,436.00 |
| Jun 30, 2025 | -145,082.00 |
| Mar 31, 2025 | -10.56 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Sep 30, 2024 | -1.98 Mn |
| Jun 30, 2024 | -14.22 Mn |
| Mar 31, 2024 | 371,773.00 |
| Dec 31, 2023 | -130,557.00 |
| Sep 30, 2023 | -4.12 Mn |
| Jun 30, 2023 | -3.93 Mn |
| Mar 31, 2023 | 932,861.00 |
| Dec 31, 2022 | -4.34 Mn |
| Sep 30, 2022 | 5.33 Mn |
| Jun 30, 2022 | -3.70 Mn |
| Mar 31, 2022 | 7.56 Mn |
| Dec 31, 2021 | 20.87 Mn |
| Sep 30, 2021 | 6.46 Mn |
| Jun 30, 2021 | 10.60 Mn |